Literature DB >> 10102137

Comparison of radial immunodiffusion and alkaline cellulose acetate electrophoresis for quantitating elevated levels of fetal hemoglobin (HbF): application to evaluating patients with sickle cell disease treated with hydroxyurea.

J C Schultz1.   

Abstract

Radial immunodiffusion (RID), alkaline cellulose acetate electrophoresis, and high-performance liquid chromatography (HPLC) were compared for quantitating the elevated (> 10%) level of fetal hemoglobin (HbF) found in the red blood cells of sickle cell disease patients undergoing treatment with hydroxyurea. HPLC- and electrophoresis-determined values were comparable. The RID-determined values were higher, in many cases twofold higher. False high HbF values would be misleading in assessing the effectiveness of hydroxyurea therapy in sickle cell disease patients. We subsequently initiated an examination of the variation in HbF values due to the use of different HbF radial immunodiffusion QUIPlates and different positions within a single plate in an attempt to determine the cause of these discrepancies. Within-run precision studies indicated that significantly different size precipitin rings were obtained depending upon which area of the plate the hemolysate containing antigen (HbF) was applied. A common feature associated with poor precision plates was a marked difference in degree of coloration of gel throughout the plate. Spuriously high HF concentrations were obtained with antigen (HbF) placed in wells located in the lighter colored gel area while antigen placed in wells in the darker colored area of the agarose gel bed were more in agreement with the electrophoretically determined HbF concentrations. The variation in HbF values was significantly greater in the diluted (HbF QUIPlate Diluent) samples than in the neat samples even on plates of uniform gel coloration. As a result of this study, we will continue to monitor high HbF levels by densitometry following alkaline cellulose acetate electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102137      PMCID: PMC6808109          DOI: 10.1002/(sici)1098-2825(1999)13:2<82::aid-jcla7>3.0.co;2-c

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  26 in total

1.  High-performance liquid chromatographic separation of human haemoglobins. Simultaneous quantitation of foetal and glycated haemoglobins.

Authors:  E Bisse; H Wieland
Journal:  J Chromatogr       Date:  1988-12-29

2.  ELISA assay for measurement of human hemoglobin A and hemoglobin F.

Authors:  M T Makler; A J Pesce
Journal:  Am J Clin Pathol       Date:  1980-11       Impact factor: 2.493

3.  Determination of fetal hemoglobin in various age groups by the immunological method of Kohn and Payne.

Authors:  G T Yüregir
Journal:  Clin Chim Acta       Date:  1976-10-15       Impact factor: 3.786

4.  High-performance liquid chromatography of human hemoglobins on a new cation exchanger.

Authors:  C N Ou; G J Buffone; G L Reimer; A J Alpert
Journal:  J Chromatogr       Date:  1983-08-26

5.  Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.

Authors:  G P Rodgers; G J Dover; C T Noguchi; A N Schechter; A W Nienhuis
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

6.  Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia.

Authors:  E Fibach; L P Burke; A N Schechter; C T Noguchi; G P Rodgers
Journal:  Blood       Date:  1993-03-15       Impact factor: 22.113

7.  Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.

Authors:  G J Dover; R K Humphries; J G Moore; T J Ley; N S Young; S Charache; A W Nienhuis
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

8.  Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia.

Authors:  S Charache; G J Dover; R D Moore; S Eckert; S K Ballas; M Koshy; P F Milner; E P Orringer; G Phillips; O S Platt
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

9.  A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.

Authors:  S P Perrine; G D Ginder; D V Faller; G H Dover; T Ikuta; H E Witkowska; S P Cai; E P Vichinsky; N F Olivieri
Journal:  N Engl J Med       Date:  1993-01-14       Impact factor: 91.245

10.  Quantification of hemoglobin variants by capillary isoelectric focusing.

Authors:  J M Hempe; R D Craver
Journal:  Clin Chem       Date:  1994-12       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.